Candidate indicators — not finalised. This bank is a working proposal for community discussion. Nothing here is an endorsed NTOG quality standard yet; the list will evolve as the Nordic community weighs in.
Screening and nodule management
QI 1Structured pulmonary nodule follow-up pathway applied
QI 2Screening eligibility documented where a programme exists
→ Detailed nodule-pathway indicator set (10 indicators, draft for review) — definitions and proposed Nordic registry mapping, open for public review.
Diagnostic pathway
QI 3Morphological (histological or cytological) verification of diagnosis
QI 4Comprehensive molecular profiling in advanced non-squamous NSCLC
QI 5PET-CT before curative-intent treatment
QI 6Brain MRI in stage III considered for curative intent
QI 7Diagnostic interval (suspicion to confirmed diagnosis) within target
MDT and treatment planning
QI 8MDT discussion before the primary treatment decision
QI 9Guideline-concordant first-line treatment plan
Core common quality indicators
QI 10Performance status documented at diagnosis
QI 11Smoking cessation support offered and documented
QI 12Patient-reported outcome (PROM) collection along the pathway
QI 13Indicators reported stratified by sex and socioeconomic position
QI 14Stage-stratified 1-year survival (outcome indicator)
Help us prioritise these indicators
We rate and discuss these candidate indicators openly on LinkedIn. Add your vote, propose a missing indicator, or tell us what would work in your setting.
Rate & discuss on LinkedIn